AZD2816

· AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD2816, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults [Phase 2, Phase 3]